New Advances in Chemical Research in 2021. In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 1029689-82-4, name is Methyl 1,2,3,4-tetrahydroisoquinoline-8-carboxylate hydrochloride, introducing its new discovery. name: Methyl 1,2,3,4-tetrahydroisoquinoline-8-carboxylate hydrochloride
Small molecule Bcl-xL inhibitors and Antibody Drug Conjugates (ADCs) comprising small molecule Bcl-xL inhibitors are disclosed herein. The Bcl-xL inhibitors and ADCs of the disclosure are useful for, among other things, inhibiting anti-apoptotic Bcl-xL proteins as a therapeutic approach towards the treatment of diseases that involve a dysregulated apoptosis pathway.
One of the oldest and most widely used commercial enzyme inhibitors is aspirin, name: Methyl 1,2,3,4-tetrahydroisoquinoline-8-carboxylate hydrochloride, which selectively inhibits one of the enzymes involved in the synthesis of molecules that trigger inflammation. you can also check out more blogs about 1029689-82-4
Reference：
Tetrahydroisoquinoline – Wikipedia,
1,2,3,4-Tetrahydroisoquinoline | C9H11N – PubChem